Published in AIDS on February 20, 2011
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31
Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era. Int J Cancer (2014) 1.16
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings. Curr Opin Oncol (2012) 0.97
Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS (2014) 0.82
The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan. BMC Infect Dis (2014) 0.81
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30
Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep (1981) 3.78
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst (2000) 3.47
Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis (2009) 3.28
Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis (2004) 2.42
The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol (2007) 2.19
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS (2002) 1.98
Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation (1972) 1.80
Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA (2000) 1.79
Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS (2001) 1.72
Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr (2005) 1.71
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70
AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist (2005) 1.69
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS (2008) 1.60
Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol (2001) 1.51
Risk of cancer in people with AIDS. AIDS (1999) 1.47
Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery (1978) 1.32
Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst (2010) 1.31
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med (2008) 1.29
The impact of the 1993 AIDS case definition on the completeness and timeliness of AIDS surveillance. AIDS (1999) 1.18
Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer (2002) 1.16
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS (2003) 1.15
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors. AIDS (2004) 1.08
Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol (2006) 1.03
Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma. CA Cancer J Clin (2005) 1.02
Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France. Clin Infect Dis (2005) 0.98
Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services. Ann Intern Med (1985) 0.86
Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma. Curr HIV Res (2006) 0.85
Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Hematol Oncol (2006) 0.82
Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One (2010) 10.39
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78
The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis (2004) 2.76
Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health (2004) 2.66
The Kenya AIDS Indicator Survey 2012: rationale, methods, description of participants, and response rates. J Acquir Immune Defic Syndr (2014) 2.54
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr (2004) 2.39
Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health (2007) 2.30
The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol (2007) 2.19
Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med (2002) 2.11
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther (2008) 1.92
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr (2009) 1.73
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr (2007) 1.66
Provision of syndromic treatment of sexually transmitted infections by community pharmacists: a potentially underutilized HIV prevention strategy. Sex Transm Dis (2003) 1.56
Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. Am J Public Health (2009) 1.43
Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS (2005) 1.42
Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer (2009) 1.42
Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis (2007) 1.40
Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr (2013) 1.34
Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr (2003) 1.31
Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29
Viagra use in a community-recruited sample of men who have sex with men, San Francisco. J Acquir Immune Defic Syndr (2003) 1.29
Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev (2005) 1.27
Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS (2004) 1.21
Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2005) 1.20
Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey. J Acquir Immune Defic Syndr (2014) 1.19
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol (2009) 1.16
The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther (2007) 1.13
Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS (2006) 1.11
A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004-2011. J Acquir Immune Defic Syndr (2013) 1.10
Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS (2013) 1.10
HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol (2010) 1.09
Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol (2010) 1.07
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS One (2013) 1.06
Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS Patient Care STDS (2014) 1.05
Assessing representativeness of sampling methods for reaching men who have sex with men: a direct comparison of results obtained from convenience and probability samples. AIDS Behav (2007) 1.04
Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav (2013) 1.03
Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. Am J Public Health (2006) 1.01
Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. J Acquir Immune Defic Syndr (2014) 1.00
Overweight in young Latino children. Arch Med Res (2008) 0.99
The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. J Acquir Immune Defic Syndr (2011) 0.98
Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011. J Infect Dis (2013) 0.98
Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDS (2014) 0.97
Acculturation and Body Mass among Latina Women. J Womens Health (Larchmt) (2008) 0.96
Examining clinic-based and public health approaches to ascertainment of HIV care status. J Acquir Immune Defic Syndr (2015) 0.95
Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr (2014) 0.95
HIV testing behaviors and knowledge of HIV reporting regulations among male-to-female transgenders. J Acquir Immune Defic Syndr (2004) 0.94
Frequent international travel by men who have sex with men recently diagnosed with HIV-1: potential for transmission of primary HIV-1 drug resistance. J Travel Med (2008) 0.94
Immigration status and use of health services among Latina women in the San Francisco Bay Area. J Womens Health (Larchmt) (2009) 0.93
Assessing receipt of medical care and disparity among persons with HIV/AIDS in San Francisco, 2006-2007. AIDS Care (2011) 0.92
Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women. Womens Health Issues (2010) 0.89
Engagement in HIV care among Kenyan adults and adolescents: results from a national population-based survey. J Acquir Immune Defic Syndr (2014) 0.89
Incidence and risk factors for verrucae in women. AIDS (2008) 0.88
Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus. Obstet Gynecol (2010) 0.88
Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002. J Health Care Poor Underserved (2006) 0.88
Smoking cessation among women with and at risk for HIV: are they quitting? J Gen Intern Med (2009) 0.87
The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003. AIDS (2005) 0.87
Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women. Cancer Epidemiol Biomarkers Prev (2013) 0.87
Use of prenatal care by Hispanic women after welfare reform. Obstet Gynecol (2006) 0.86
A randomized control trial of personalized cognitive counseling to reduce sexual risk among HIV-infected men who have sex with men. AIDS Care (2012) 0.86
Does name-based HIV reporting deter high-risk persons from HIV testing? Results from San Francisco. J Acquir Immune Defic Syndr (2004) 0.85
People fifty years or older now account for the majority of AIDS cases in San Francisco, California, 2010. AIDS Care (2013) 0.84
The Guinea pig as a preclinical model for demonstrating the efficacy and safety of statins. J Pharmacol Exp Ther (2007) 0.84
Efficacy of personalized cognitive counseling in men of color who have sex with men: secondary data analysis from a controlled intervention trial. AIDS Behav (2011) 0.83
Measuring the unknown: calculating community viral load among HIV-infected MSM unaware of their HIV status in San Francisco from National HIV Behavioral Surveillance, 2004-2011. J Acquir Immune Defic Syndr (2013) 0.82
Correlating knowledge of cervical cancer prevention and human papillomavirus with compliance after colposcopy referral. J Low Genit Tract Dis (2012) 0.82
Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS (2014) 0.82
Negative predictive value of pap testing: implications for screening intervals for women with human immunodeficiency virus. Obstet Gynecol (2012) 0.82
Using HIV testing history to measure the success of HIV partner services. Sex Transm Dis (2013) 0.82
The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Int J STD AIDS (2013) 0.79
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis (2004) 0.79
Disparities and Trends in Viral Suppression During a Transition to a "Test and Treat" Approach to the HIV Epidemic, San Francisco, 2008-2012. J Acquir Immune Defic Syndr (2015) 0.79
Sexual compulsiveness and change in unprotected anal intercourse: unexpected results from a randomized controlled HIV counseling intervention study. J Acquir Immune Defic Syndr (2008) 0.79
Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One (2013) 0.78
Hair changes in women from the Women's Interagency HIV Study. Arch Dermatol (2003) 0.77
Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco. J Acquir Immune Defic Syndr (2015) 0.77
How well do trends in HIV prevalence in young people reflect HIV incidence? Results from 10 years of HIV serosurveillance in San Francisco. AIDS (2006) 0.77
Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco. J Acquir Immune Defic Syndr (2016) 0.77
Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women. AIDS Care (2011) 0.76
Using a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites. J Acquir Immune Defic Syndr (2016) 0.75
Risk of breast cancer with CXCR4-using HIV defined by V3 loop sequencing. J Acquir Immune Defic Syndr (2015) 0.75
Maternal acculturation and the prenatal care experience. J Womens Health (Larchmt) (2014) 0.75
Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy. Int J Dermatol (2013) 0.75
Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma. AIDS (2015) 0.75
Plasma biomarkers for detecting Hodgkin's lymphoma in HIV patients. PLoS One (2011) 0.75
Estimating the Prevalence and Predictors of Incorrect Condom Use Among Sexually Active Adults in Kenya: Results From a Nationally Representative Survey. Sex Transm Dis (2016) 0.75
Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. J Acquir Immune Defic Syndr (2017) 0.75
Antiretroviral Prescription and Viral Suppression in a Representative Sample of HIV-Infected Persons in Care in Four Large Metropolitan Areas of the United States, Medical Monitoring Project, 2011[FIGURE DASH]2013. J Acquir Immune Defic Syndr (2017) 0.75